Many prescription and over-the-counter medications can produce skin reactions ranging from mild rashes to severe eruptions, acne-like breakouts, increased pigmentation, and hair loss. Recognising a drug-induced skin change early and discussing it with your physician is essential — never stop a prescribed medication without medical guidance.
Why Do Medications Cause Skin Reactions?
The skin is the largest organ in the human body and is frequently affected by systemic medications. Drug-induced skin reactions (also called cutaneous adverse drug reactions) account for approximately 2–3% of all dermatology consultations and represent one of the most common adverse effects seen in clinical practice. They can occur via several mechanisms:
- Immunological reactions: The drug or its metabolite triggers an immune response (e.g., allergic contact dermatitis, drug hypersensitivity syndrome).
- Non-immunological reactions: Direct toxic effects on skin cells, interference with hormonal pathways, or photosensitisation.
- Pharmacological side effects: Predictable reactions resulting from the drug's mechanism of action (e.g., corticosteroid-induced skin thinning).
Understanding which medications affect the skin — and how — helps patients and clinicians identify reactions early, adjust treatment plans, and protect skin health during long-term therapy.
Acneiform Eruptions (Drug-Induced Acne)
Drug-induced acneiform eruptions resemble acne vulgaris but are typically monomorphic (all lesions at the same stage), appear abruptly, and often lack true comedones. They can affect areas not typically prone to acne such as the trunk, shoulders and arms.
Common Causative Drugs
- Corticosteroids (oral and topical): One of the most frequent causes. Systemic steroids stimulate sebaceous glands and alter follicular keratinisation. Topical steroids on the face can cause perioral dermatitis and steroid-induced acne.
- Anabolic androgenic steroids: Strongly androgenic; dramatically increase sebum production and can cause severe nodulocystic acne on the face, back and chest.
- Lithium: Used in bipolar disorder. Exacerbates existing acne and can trigger new-onset acneiform lesions, particularly on the trunk.
- Anticonvulsants: Phenytoin and certain other anticonvulsants have been associated with acneiform changes.
- Isoniazid: Used in tuberculosis treatment; can cause acne-like eruptions, especially in slow acetylators.
- EGFR inhibitors: Targeted cancer therapies (erlotinib, cetuximab) frequently cause papulopustular rashes on the face and scalp that closely resemble acne.
- High-dose B vitamins (B12, B6): Supplemental doses significantly above the recommended daily allowance have been linked to acneiform breakouts.
Drug-Induced Rashes and Urticaria
Maculopapular exanthems — widespread flat-to-slightly-raised pink or red spots — are the most common pattern of drug rash. They typically appear within 1–2 weeks of starting a new medication and resolve after discontinuation. Urticaria (hives) can also be drug-induced, presenting as itchy wheals that come and go.
Medications Commonly Causing Rashes
- Antibiotics: Penicillins and cephalosporins are the most common antibiotic triggers. Ampicillin causes a characteristic non-allergic maculopapular rash in nearly 100% of patients with infectious mononucleosis.
- Allopurinol: Used for gout; one of the most common causes of severe cutaneous adverse reactions including Stevens-Johnson syndrome in certain genetic populations.
- Non-steroidal anti-inflammatory drugs (NSAIDs): Aspirin, ibuprofen and naproxen can cause urticaria and angioedema, particularly in patients with underlying chronic urticaria.
- ACE inhibitors: Associated with angioedema — sudden swelling of the lips, tongue and throat — which can be life-threatening.
- Anticonvulsants: Carbamazepine, lamotrigine and phenytoin carry a risk of severe reactions including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Warning Signs Requiring Urgent Medical Attention
Not all drug rashes are mild. The following features should prompt immediate medical evaluation:
- Blistering or skin peeling (possible Stevens-Johnson syndrome or toxic epidermal necrolysis)
- Rash accompanied by fever, facial swelling, or enlarged lymph nodes (possible DRESS syndrome)
- Mucosal involvement (mouth, eyes, genitals)
- Rapid spread of the rash
- Difficulty breathing or swallowing alongside a skin reaction
Drug-Induced Pigmentation Changes
Several medications alter melanin production or cause pigment deposits in the skin, resulting in darkening, patchy discolouration, or unusual colour changes.
Types of Drug-Induced Pigmentation
- Hyperpigmentation: Darkening of the skin, often in sun-exposed areas. Common with antimalarials (hydroxychloroquine, chloroquine), amiodarone, minocycline, and oral contraceptives.
- Minocycline pigmentation: This antibiotic can cause three distinct patterns — blue-black discolouration at sites of previous inflammation, blue-grey pigmentation over sun-exposed areas, or diffuse muddy-brown discolouration.
- Amiodarone pigmentation: This cardiac medication causes a slate-grey to blue-violet discolouration on sun-exposed areas, particularly the face, in up to 75% of long-term users.
- Chemotherapy agents: Many cytotoxic drugs (bleomycin, busulfan, cyclophosphamide, 5-fluorouracil) cause diffuse or patterned hyperpigmentation. Bleomycin classically produces "flagellate" linear streaks.
- Hypopigmentation: Less common; can occur with certain topical agents or systemic steroids used long-term.
Drug-induced pigmentation often improves after stopping the offending drug, but minocycline and amiodarone changes can persist for years. Laser treatments may be considered for persistent cases after the drug is discontinued.
Drug-Induced Hair Loss (Telogen Effluvium)
Medication is one of the most overlooked causes of diffuse hair shedding. Drug-induced alopecia most commonly presents as telogen effluvium — a diffuse, non-scarring hair loss that begins 2–4 months after starting the offending drug as resting (telogen) hairs are prematurely shed.
Drugs Associated with Hair Loss
- Anticoagulants: Heparin and warfarin; hair loss typically begins 3 months after initiation.
- Retinoids: Both oral isotretinoin (for severe acne) and acitretin (for psoriasis) can cause diffuse thinning.
- Antithyroid drugs: Carbimazole and propylthiouracil.
- Beta-blockers: Propranolol and metoprolol are the most commonly implicated.
- Antidepressants and mood stabilisers: Lithium, valproate, and some SSRIs.
- Chemotherapy agents: Cause anagen effluvium — rapid, often complete hair loss — by disrupting the actively dividing hair matrix cells.
- Hormonal contraceptives: Can trigger or exacerbate androgenetic alopecia in genetically susceptible individuals.
Drug-induced telogen effluvium is generally reversible within 3–6 months of discontinuing the causative medication. Platelet-rich plasma (PRP) therapy and mesotherapy may support regrowth during recovery.
Photosensitivity Reactions
Some medications make the skin abnormally sensitive to ultraviolet radiation, leading to exaggerated sunburn, rashes, or long-term pigmentation in sun-exposed areas. This is known as drug-induced photosensitivity.
Common Photosensitising Drugs
- Tetracycline antibiotics (especially doxycycline): Commonly prescribed for acne, they significantly increase UV sensitivity. High-factor sun protection is mandatory.
- Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin)
- Thiazide diuretics (hydrochlorothiazide): Widely used for hypertension; linked to an increased risk of squamous cell carcinoma with chronic UV exposure.
- NSAIDs: Ketoprofen and piroxicam have particular photosensitising potential.
- Phenothiazines: Antipsychotics such as chlorpromazine.
- Amiodarone: Causes both phototoxicity and photoallergy.
- St John's Wort (Hypericum perforatum): This herbal supplement — widely taken for mild depression — is a potent photosensitiser and should be considered a medication for interaction purposes.
Patients on photosensitising drugs should apply a broad-spectrum SPF 50+ sunscreen daily and minimise direct sun exposure, particularly between 10:00 and 16:00.
Other Skin Changes Caused by Medications
Skin Thinning and Striae
Prolonged use of topical or systemic corticosteroids causes skin atrophy — thinning, increased fragility, easy bruising, and stretch marks (striae). This is particularly problematic when potent topical steroids are used on thin skin areas such as the face, axillae, or groin. The fluorinated topical steroids carry the highest atrophogenic risk.
Drug-Induced Psoriasis Flares
Several drugs can trigger or worsen psoriasis in predisposed individuals:
- Beta-blockers (propranolol)
- Lithium
- Antimalarials (chloroquine, hydroxychloroquine)
- ACE inhibitors
- Systemic corticosteroid withdrawal
Drug-Induced Lupus
Certain medications (hydralazine, procainamide, minocycline, isoniazid) can induce a lupus-like syndrome with a characteristic butterfly-shaped facial rash, photosensitivity, and joint symptoms. This is generally reversible on drug discontinuation.
Aesthetic Treatments and Medications: What to Consider
Patients undergoing aesthetic treatments should always inform their practitioner of all medications they are taking. Several drugs require special planning:
- Oral retinoids (isotretinoin): Ablative laser resurfacing, chemical peels, dermabrasion and some energy-based treatments are generally contraindicated during treatment and for at least 6 months after completion, due to impaired wound healing.
- Anticoagulants and antiplatelet drugs: Increase bruising risk with injectable treatments. The prescribing physician should advise whether temporary discontinuation is safe before elective procedures.
- Immunosuppressants: Increased infection risk; procedures that breach the skin barrier require careful sterility protocols and may need to be postponed.
- Photosensitising drugs: Contraindicated for IPL, certain laser wavelengths, and photodynamic therapy without specialist assessment.
- Corticosteroids (long-term): Impair wound healing and increase the risk of post-procedure infection and poor scarring.
Please contact us for pricing on treatments that may help manage drug-related skin changes — pricing varies based on individual assessment.
Conclusion
Drug-induced skin reactions are common, diverse, and sometimes serious. Recognising the pattern — whether acne, rash, pigmentation change, hair loss, or photosensitivity — and linking it to a recent medication change is the critical first step. Always work with your prescribing physician before adjusting or stopping any medication, and consult a dermatologist for assessment and management of the skin reaction itself.
If you are concerned about a skin change that may be related to a medication you are taking, or if you need to plan an aesthetic procedure around a specific drug regimen, our team at Virtuana Clinic is available for consultation.
References
- Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. "Antibiotic allergy." Lancet. 2019;393(10167):183-198. [PubMed]
- Ziemer M, Paasch U. "Drug-induced acneiform eruptions." J Dtsch Dermatol Ges. 2020;18(5):475-495.
- Dereure O. "Drug-induced skin pigmentation." Am J Clin Dermatol. 2001;2(4):253-262. [PubMed]
- Hughes EC, Saleh D. "Telogen Effluvium." In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. [NCBI]
- Drucker AM, Rosen CF. "Drug-induced photosensitivity." Drug Saf. 2011;34(10):821-837. [PubMed]
This article is for informational purposes only. Please consult a qualified physician for diagnosis and treatment decisions.